Cambridge Cognition inks deal with India-based Ivory
16th Feb 2026 13:25
(Sharecast News) - Cambridge Cognition announced on Monday that it has entered into a commercialisation agreement with India-based brain health platform Ivory to deploy its 'CANTAB Pathway' digital cognitive assessment tool across healthcare and consumer health markets in India.
Read moreCambridge Cognition reports rebound in commercial momentum
19th Jan 2026 13:17
(Sharecast News) - Cambridge Cognition reported a sharp rebound in commercial momentum on Monday, with new sales orders rising strongly and the order book expanding in 2025, although full-year revenue fell as expected due to a weaker opening backlog.
Read moreCambridge Cognition's Monument enters schizophrenia partnership with FNIH
19th Aug 2025 10:14
(Sharecast News) - Cambridge Cognition said on Tuesday that Monument Therapeutics, in which it holds a 20% stake, has partnered with the Foundation for the National Institutes of Health to trial a new treatment for schizophrenia.
Read moreCambridge Cognition secures £1m contract with 'major pharmaceutical company'
10th Apr 2025 11:52
(Sharecast News) - Software group Cambridge Cognition said on Thursday that it has secured a £1.0m contract to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinical trial.
Read moreCambridge Cognition product used in schizophrenia treatment trial
8th Jan 2025 14:25
(Sharecast News) - Cambridge Cognition announced the use of its 'CANTAB' cognitive assessment product in two phase three clinical trials conducted by Bristol Myers Squibb for 'Cobenfy', a newly FDA-approved treatment for schizophrenia.
Read moreCambridge Cognition FY revenues seen at no less than £10m
10th Dec 2024 10:39
(Sharecast News) - Brain health software group Cambridge Cognition said on Tuesay that full-year revenues were expected to be no less than £10.0m, while adjusted underlying earnings was seen at close to breakeven.
Read moreCambridge Cognition ex-CEO resigns as director
18th Oct 2024 11:40
(Sharecast News) - Cambridge Cognition, a provider of digital solutions for assessing brain health, announced the formal resignation of Dr Matthew Stork as a director of the company and its subsidiaries on Friday.
Read moreCambridge Cognition forms scientific advisory board
21st Mar 2024 16:26
(Sharecast News) - Digital brain health solutions developer Cambridge Cognition announced the creation of a scientific advisory board on Thursday.
Read moreCambridge Cognition inks strategic partnership with ActiGraph
21st Feb 2024 12:17
(Sharecast News) - Brain health specialist Cambridge Cognition announced a strategic partnership with ActiGraph, a provider of wearable technologies tailored for clinical trials, on Wednesday.
Read moreCambridge Cognition secures 'significant contract'
11th Oct 2023 10:04
(Sharecast News) - Digital solutions group Cambridge Cognition has secured a "significant contract" for a "sizeable" later-stage clinical trial, following a competitive tender.
Read moreCambridge Cognition wins £2m cancer therapy trial contract
13th Jun 2023 14:45
(Sharecast News) - Brain health assessment specialist Cambridge Cognition has secured a £2m contract for a significant cancer therapy trial, it announced on Tuesday.
Read moreCambridge Cognition wins two contracts worth £2.1m
12th Apr 2023 14:32
(Sharecast News) - Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2.1m, it announced on Wednesday.
Read moreDirector dealings: Cambridge Cognition CEO makes share purchase
6th Feb 2023 15:11
(Sharecast News) - Cambridge Cognition revealed on Monday that chief executive Matthew Stork had acquired 13,500 ordinary shares in the AIM-listed technology company.
Read moreCambridge Cognition finds local partner for China expansion
24th Nov 2022 13:30
(Sharecast News) - Brain health technology developer Cambridge Cognition announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare on Thursday.
Read moreCambridge Cognition agrees £1.7m purchase of eClinicalHealth
12th Oct 2022 13:01
(Sharecast News) - Brain health specialise Cambridge Cognition has agreed to acquire virtual clinical trial solution provider eClinicalHealth (eCH), it announced on Wednesday, for up to £1.7m.
Read more